Transduction of CD34+ hematopoietic progenitor cells with an antitat gene protects T-cell and macrophage progeny from AIDS virus infection

Journal of Virology

Volumn 71, Issue 4, 1997, Pages 2740-2746

  Rosenzweig, Michael ^a   Marks, Douglas F ^a   Hempel, Donna ^a   Lisziewicz, Julianna ^b   Johnson, R Paul ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Res Inst Genetic and Hum Ther   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; RNA; TRANSACTIVATOR PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0030932983     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.4.2740-2746.1997     Document Type: Article

References (45)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, W. R., A. Rabson, and M. H. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and non-human cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Arya, S. K., C. Guo, S. F. Josephs, and F. Wong-Staal. 1985. Transactivator gene of human T-lymphotropic virus type III (HTLV-III). Science 229-69-73.
3. + hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type 1 replication in myelomonocytic cells produced in long-term culture. J. Virol. 70:4352-4360.
4. Baltimore, D. 1988. Intracellular immunization. Nature 335:395-396.
5. Blue, M. L., J. F. Daley, H. Levine, and S. F. Schlossman. 1985. Co-expression of T4 and T8 on peripheral blood T cells demonstrated by two-color fluorescence flow cylometry. J. Immunol. 134:228-234.
6. Bridges, S. H., and N. Sarver. 1995. Gene therapy and immune restoration for HIV disease. Lancet 345:427-432.
7. Cassel, A., M. Cottier-Fox, S. Doren, and C. E. Dunbar. 1993. Retroviral-mediated gene transfer into CD34-enriched human peripheral blood stem cells. Exp. Hematol. 21:585-591.
8. Chen, Z. W., Z.-C. Kou, L. Shen, K. A. Reimann, and N. L. Letvin. 1993. Conserved T-cell receptor repertoire in simian immunodeficiency virus-infected rhesus monkeys. J. Immunol. 151:2177-2187.
9. Dayton, A. I., J. G. Sodroski, C. A. Rosen, W. C. Goh, and W. A. Haseltine. 1986. The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell 44:941-947.
10. Dunbar, C. E., M. Cottier-Fox, J. A. O'Shaughnessy, S. Doren, C. Carter, R. Berenson, S. Brown, R. C. Moen, J. Greenblatt, F. M. Stewart, S. F. Leitman, W. H. Wilson, K. Cowan, N. S. Young, and A. W. Nienhuis. 1995. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 85:3048.
11. Hantzopoulos, P. A., B. A. Sullenger, G. Ungers, and E. Gilboa. 1989. Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector. Proc. Natl. Acad. Sci. USA 86:3519-3523.
12. Harbol, A. W., J. L. Liesveld, P. J. Simpson-Haidaris, and C. N. Abboud. 1994. Mechanisms of cytopenia in human immunodeficiency virus infection. Blood Rev. 8:241-251.
13. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
14. Kawai, T., J. Wong, J. MacLean, A. B. Cosimi, and S. Wee. 1994. Characterization of a monoclonal antibody (6G12) recognizing the cynomolgus monkey CD3 antigen. Transplant. Proc. 26:1845-1846.
15. Kestler, H., T. Kodama, D. Ringler, M. Marthas, N. Pedersen, A. Lackner, D. Regier, P. Sehgal, M. Daniel, N. King, and R. Desrosiers. 1990. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248:1109-1112.
16. Kindt, T. J., V. M. Hirsch, P. R. Johnson, and S. Sawasdikosol. 1992. Animal models for acquired immunodeficiency syndrome. Adv. Immunol. 52:425-475.
17. Li, J., C. I. Lord, W. Haseltine, N. L. Letvin, and J. Sodroski. 1992. Infection of cynomologus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins. J. Acquired Immune Defic. Syndr. 5:639-646.
18. Lim, B., J. F. Apperly, S. H. Orkin, and D. A. Williams. 1989. Long-term expression of human adenosine deaminase in mice transplanted with retrovirus-infected hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 86:8892-8896.
19. Lisziewicz, J., D. Sun, A. Lisziewicz, and R. C. Gallo. 1995. Antitat gene therapy: a candidate for late-stage AIDS patients. Gene Ther. 2:218-222.
20. Lisziewicz, J., D. Sun, J. Smythe, P. Lusso, F. Lori, A. Louie, P. Markham, J. Rossi, M. Reitz, and R. C. Gallo. 1993. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS. Proc. Natl. Acad. Sci. USA 90:8000-8004.
21. Lisziewicz, J., D. Sun, B. Trapnell, M. Thomson, H.-K. Chang, B. Ensoli, and B. Peng. 1995. An autoregulated dual-function antitat gene for human immunodeficiency virus type 1 gene therapy. J. Virol. 69:206-212.
22. Lori, F., J. Lisziewicz, J. Smythe, A. Cara, T. A. Bunnag, D. Curiel, and R. C. Gallo. 1994. Rapid protection against human immunodeficiency virus type 1 (HIV-1) replication mediated by high efficiency non-retroviral delivery of genes interfering with HIV-1 tat and gag. Gene Ther. 1:27-31.
23. Miller, A. D., J. V. Garcia, N. von Suhr, C. M. Lynch, C. Wilson, and M. V. Eiden. 1991. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65:2220-2224.
24. Moore, K. A., A. B. Deisseroth, C. L. Reading, D. E. Williams, and J. W. Belmont. 1992. Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells. Blood 79:1393-1399.
25. Mori, K., D. J. Ringler, T. Kodama, and R. C. Desrosiers. 1992. Complex determinants of macrophage tropism in env of simian immunodeficiency virus. J. Virol. 66:2067-2075.
26. Nabel, G. J. 1994. Gene therapy approaches to AIDS. AIDS 8:S61-S69.
27. Nolta, J. A., E. M. Smogorzewska, and D. B. Kohn. 1995. Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood 86:101-110.
28. Ogawa, M. 1993. Differentiation and proliferation of hematopoietic stem cells. Blood 81:2844-2853.
29. Pomerantz, R. J., and D. Trono. 1995. Genetic therapies for HIV infections: promise for the future. AIDS 9:985-993.
30. Riddell, S. R., M. Elliott, D. A. Lewinsohn, M. J. Gilbert, L. Wilson, S. A. Manley, S. D. Lupton, R. W. Overell, T. C. Reynolds, L. Corey, and P. D. Greenberg. 1996. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat. Med. 2:216-223.
31. Rosenzweig, M., et al. Unpublished data.
32. Rosenzweig, M., D. Hempel, and R. P. Johnson. Unpublished data.
33. Rosenzweig, M., D. F. Marks, H. Zhu, D. Hempel, K. G. Mansfield, P. K. Sehgal, S. Kalams, D. T. Scadden, and R. P. Johnson. 1996. In vitro T lymphopoiesis of human and rhesus CD34+ progenitor cells. Blood 87: 4040-4048.
34. Sodroski, J., R. Patarca, C. Rosen, F. Wong-Staal, and W. A. Haseltine. 1985. Location of the trans-activating region of the genome of human T-cell lymphotropic virus type III. Science 229:74-77.
35. Spits, H., L. L. Lanier, and J. H. Phillips. 1995. Development of human T and natural killer cells. Blood 85:2654-2670.
36. Sutherland, D. R., and C. J. Eaves. 1994. Culture of hematopoietic cells, p. 139-162. Wiley-Liss, New York, N.Y.
37. Tao, J., and A. D. Frankel. 1993. Electrostatic interactions modulate the RNA-binding and transactivation specificities of the human immunodeficiency virus and simian immunodeficiency virus Tat proteins. Proc. Natl. Acad. Sci. USA 90:1571-1575.
38. U.S. Department of Health and Human Services. 1985. Guide for the care and use of laboratory animals. DHHS publication no. 85-23. U.S. Department of Health and Human Services, Washington, D.C.
39. van Ewijk, W. 1991. T-Cell differentiation is influenced by thymic microenvironments. Annu. Rev. Immunol. 9:591-615.
40. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122.
41. Weissman, I. L. 1993. The whole body view. Curr. Biol. 3:766-769.
42. Woffendin, C., U. Ranga, Z.-Y. Yang, L. Xu, and G. J. Nabel. 1996. Expression of a protective gene prolongs survival of T cells in human immunodeficiency virus-infected patients. Proc. Natl. Acad. Sci. USA 93:2889-2894.
43. Wong, J. T., and R. B. Colvin. 1987. Bi-specific monoclonal antibodies: selective binding and complement fixation to cells that express two different surface antigens. J. Immunol. 139:1369-1374.
44. Xu, L. C., S. Karlsson, E. R. Byrne, S. Kluepfel-Slahl, S. W. Kessler, B. A. Agricola, S. Sellers, M. Kirby, C. E. Dunbar, R. O. Brady, A. W. Nienhuis, and R. E. Donahue. 1995. Long-term in vivo expression of the human glucocerebrosidase gene in nonhuman primates after CD34+ hematopoietic cell transduction with cell-free retroviral vector preparations. Proc. Natl. Acad. Sci. USA 92:4372-4376.
45. Yu, M., M. C. Leavitt, M. Maruyama, O. Yamada, D. Young, A. D. Ho, and F. Wong-Staal. 1995. Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 92:699-703.